537 related articles for article (PubMed ID: 15801012)
21. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis.
Kosinski M; Zhao SZ; Dedhiya S; Osterhaus JT; Ware JE
Arthritis Rheum; 2000 Jul; 43(7):1478-87. PubMed ID: 10902749
[TBL] [Abstract][Full Text] [Related]
22. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 1 receptor antagonist anakinra improves functional status in patients with rheumatoid arthritis.
Cohen SB; Woolley JM; Chan W;
J Rheumatol; 2003 Feb; 30(2):225-31. PubMed ID: 12563672
[TBL] [Abstract][Full Text] [Related]
24. Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2,491 rheumatoid arthritis patients following leflunomide initiation.
Wolfe F
J Rheumatol; 2001 May; 28(5):982-9. PubMed ID: 11361226
[TBL] [Abstract][Full Text] [Related]
25. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
[TBL] [Abstract][Full Text] [Related]
26. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
van der Heijde D; Klareskog L; Singh A; Tornero J; Melo-Gomes J; Codreanu C; Pedersen R; Freundlich B; Fatenejad S
Ann Rheum Dis; 2006 Mar; 65(3):328-34. PubMed ID: 16079172
[TBL] [Abstract][Full Text] [Related]
27. Generic quality-of-life assessment in rheumatoid arthritis.
Tugwell P; Idzerda L; Wells GA
Am J Manag Care; 2007 Dec; 13 Suppl 9():S224-36. PubMed ID: 18095786
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
[TBL] [Abstract][Full Text] [Related]
30. Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.
Emery P; Kosinski M; Li T; Martin M; Williams GR; Becker JC; Blaisdell B; Ware JE; Birbara C; Russell AS
J Rheumatol; 2006 Apr; 33(4):681-9. PubMed ID: 16568505
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of sulfasalazine and methotrexate in 1102 DMARD-naive patients with early RA.
Lie E; Uhlig T; van der Heijde D; Rødevand E; Kalstad S; Kaufmann C; Mikkelsen K; Kvien TK
Rheumatology (Oxford); 2012 Apr; 51(4):670-8. PubMed ID: 22157597
[TBL] [Abstract][Full Text] [Related]
32. Effects of double filtration plasmapheresis, leflunomide, and methotrexate on inflammatory changes found through magnetic resonance imaging in early rheumatoid arthritis.
Yu X; Wang L; Xu P; Lu W; Lan G; Ping L; Wang X; Tian J; Liu J
J Rheumatol; 2012 Jun; 39(6):1171-8. PubMed ID: 22505700
[TBL] [Abstract][Full Text] [Related]
33. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
34. Using Rasch analysis to compare the psychometric properties of the Short Form 36 physical function score and the Health Assessment Questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis.
Taylor WJ; McPherson KM
Arthritis Rheum; 2007 Jun; 57(5):723-9. PubMed ID: 17530670
[TBL] [Abstract][Full Text] [Related]
35. The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial.
Bingham CO; Weinblatt M; Han C; Gathany TA; Kim L; Lo KH; Baker D; Mendelsohn A; Westhovens R
J Rheumatol; 2014 Jun; 41(6):1067-76. PubMed ID: 24786931
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
37. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L
J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452
[TBL] [Abstract][Full Text] [Related]
38. A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis.
Choi HK; Seeger JD; Kuntz KM
J Rheumatol; 2002 Jun; 29(6):1156-65. PubMed ID: 12064828
[TBL] [Abstract][Full Text] [Related]
39. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.
van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Ewals JA; Han KH; Hazes JM; Kerstens PJ; Peeters AJ; van Zeben D; Breedveld FC; Huizinga TW; Dijkmans BA; Allaart CF
Arthritis Rheum; 2009 Jan; 61(1):4-12. PubMed ID: 19116965
[TBL] [Abstract][Full Text] [Related]
40. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.
Farahani P; Levine M; Gaebel K; Thabane L
Can J Clin Pharmacol; 2005; 12(3):e254-63. PubMed ID: 16278497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
